BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24658276)

  • 1. Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice.
    Contreras-Vallejos E; Utreras E; Bórquez DA; Prochazkova M; Terse A; Jaffe H; Toledo A; Arruti C; Pant HC; Kulkarni AB; González-Billault C
    PLoS One; 2014; 9(3):e90363. PubMed ID: 24658276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.
    Morabito MA; Sheng M; Tsai LH
    J Neurosci; 2004 Jan; 24(4):865-76. PubMed ID: 14749431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Sox6 by cyclin dependent kinase 5 in brain.
    Rudrabhatla P; Utreras E; Jaffe H; Kulkarni AB
    PLoS One; 2014; 9(3):e89310. PubMed ID: 24662752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts.
    Toledo A; Zolessi FR; Arruti C
    PLoS One; 2013; 8(4):e62863. PubMed ID: 23634231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
    Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
    J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myristoylated alanine-rich C kinase substrate (MARCKS), a major protein kinase C substrate, is an in vivo substrate of proline-directed protein kinase(s). A mass spectroscopic analysis of the post-translational modifications.
    Taniguchi H; Manenti S; Suzuki M; Titani K
    J Biol Chem; 1994 Jul; 269(28):18299-302. PubMed ID: 8034575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins.
    Zhou J; Wang H; Feng Y; Chen J
    Life Sci; 2010 Mar; 86(13-14):532-7. PubMed ID: 20153752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum.
    Chergui K; Svenningsson P; Greengard P
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2191-6. PubMed ID: 14769920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372.
    Coddou C; Sandoval R; Castro P; Lazcano P; Hevia MJ; Rokic M; Hall B; Terse A; Gonzalez-Billault C; Kulkarni AB; Stojilkovic SS; Utreras E
    Pain; 2017 Nov; 158(11):2155-2168. PubMed ID: 28809765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
    Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
    J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
    Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
    Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation by PKA and Cdk5 Mediates the Early Effects of Synapsin III in Neuronal Morphological Maturation.
    Piccini A; Perlini LE; Cancedda L; Benfenati F; Giovedì S
    J Neurosci; 2015 Sep; 35(38):13148-59. PubMed ID: 26400944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor.
    Ikenoya M; Hidaka H; Hosoya T; Suzuki M; Yamamoto N; Sasaki Y
    J Neurochem; 2002 Apr; 81(1):9-16. PubMed ID: 12067241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 phosphorylates endothelial nitric oxide synthase at serine 116.
    Cho DH; Seo J; Park JH; Jo C; Choi YJ; Soh JW; Jo I
    Hypertension; 2010 Feb; 55(2):345-52. PubMed ID: 20048197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk5 regulates Rap1 activity.
    Utreras E; Henriquez D; Contreras-Vallejos E; Olmos C; Di Genova A; Maass A; Kulkarni AB; Gonzalez-Billault C
    Neurochem Int; 2013 May; 62(6):848-53. PubMed ID: 23416045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
    Kesavapany S; Lau KF; McLoughlin DM; Brownlees J; Ackerley S; Leigh PN; Shaw CE; Miller CC
    Eur J Neurosci; 2001 Jan; 13(2):241-7. PubMed ID: 11168528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
    Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
    Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) by proline-directed protein kinases and its dephosphorylation.
    Yamamoto H; Arakane F; Ono T; Tashima K; Okumura E; Yamada K; Hisanaga S; Fukunaga K; Kishimoto T; Miyamoto E
    J Neurochem; 1995 Aug; 65(2):802-9. PubMed ID: 7616238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.